Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지

Cytokeratin 15 is an Effective Indicator for Progression and Malignancy of Esophageal Squamous Cell Carcinomas

  • Published : 2016.09.01
⟨ Previous Next ⟩

Abstract

Purpose: To compare the expression level of CK 15 in normal esophageal and esophageal squamous-cell carcinoma (ESCC) tissues and analyse possible functions of CK15 in occurrence and development. Materials and Methods: Immunohistochemistry was used to compare CK14, CK15 and proliferating cell nuclear antigen (PCNA) expression levels in ESCCs. Expression level of CK15 was also assessed by Western blotting. In addition, levels of CK15, cytokeratin 19 fragment antigen 21-1 (CYFRA21-1) and PCNA were detected in serum by enzymelinked immunosorbent assay (ELISA) and chemiluminescence methods. Relationships between clinicopathological parameters and CK14 and CK15 expression were then analyzed. Results: According to immunohistochemistry, in esophageal and intraepithelial neoplasia (SIN) tissues, the expression of CK14, CK15 and PCNA localized to basal layer of the epithelium. CK14 and CK15 levels were higher in normal esophageal squamous epithelial tissue than in SIN and ESCC, and greater in highly differentiated than poorly differentiated carcinoma tissue. By Western blotting, we found more pronounced expression of CK15 in normal esophageal tissue, compared with carcinoma tissue. The specificity of changed CK15 and CYFRA21-1 expression was respectively 90.0% and 96.7% in serum of ESCC patients. Joint detection could improve the sensitivity of esophageal carcinoma diagnosis. Relationships between CK14, CK15 expression and clinical parameters were not statistically significant (P>0.05). Postoperative survival in patients of CK14, CK15 positive expression was longer than with negative expression ($x^2=4.35$, P=0.037; $x^2=9.852$, P=0.002). Conclusions: CK15 expression decreased in esophageal squamous cell carcinoma tissue and serum of esophageal squamous carcinoma patients. We infer that CK15 may play an important role for the occurrence and development of esophageal squamous-cell carcinoma. In the future, CK15 may be used for the diagnosis, treatment and prognostic evaluation of esophageal squamous-cell carcinoma.

Keywords

References

  1. Bragulla HH, Homberger DG, (2009). Structure and functions of keratin proteins in simple, stratified, keratinized and cornified epithelia. J Anat, 214, 516-59. https://doi.org/10.1111/j.1469-7580.2009.01066.x
  2. Fuchs E, (1995). Keratins and the skin. Annu Rev Cell Dev Biol, 11, 123-53. https://doi.org/10.1146/annurev.cb.11.110195.001011
  3. Gu LH, Coulombe PA, (2007). Keratin function in skin epithelia: a broadening palette with surpriseing shades. Curr Opin Cell Biol, 19, 13-23. https://doi.org/10.1016/j.ceb.2006.12.007
  4. Khanom R, Sakamoto K, Pal SK, et al (2012). Expression of basal cell keratin 15 and keratin 19 in oral squamous neoplasms represents diverse pathophysiologies, Histol Histopathol, 27, 949-59.
  5. Leube RE, Bader BL, Bosch FX, et al (1988). Molecular characterization and expression of the stratification-related cytokeratins 4 and 15. J Cell Biol, 106, 1249-61. https://doi.org/10.1083/jcb.106.4.1249
  6. Liu Y, Lyle S, Yang Z, et al (2003). Keratin15 promoter targets putative epithelial stem cells in the hair follicle bulge. J Invest Dermatol, 121, 963-8. https://doi.org/10.1046/j.1523-1747.2003.12600.x
  7. Moll R, Divo M, Langbein L, (2008). The human keratins: biology and pathology. Histochem Cell Bio, 129, 705-33. https://doi.org/10.1007/s00418-008-0435-6
  8. Mailand N, Gibbs-Seymour I, Bekker-Jensen S, (2013). Regulation of PCNA-protein interactions for genome stability. Nat Rev Mol Cell Biol, 14, 269-82. https://doi.org/10.1038/nrm3562
  9. Porter RM, Lunny DP, Ogden PH, et al (2000). K15 expression implies lateral differentiation within stratified epithelial basal cells. Lab Invest, 80, 1701-10. https://doi.org/10.1038/labinvest.3780180
  10. Pontiggia L, Biedermann T, Meuli M, et al (2009). Markers to evaluate the quality and self-renewing potential of engineered human skin substitutes in vitro and after transplantation. J Invest. Dermatol, 129, 480-90.
  11. Sakamoto K, Aragaki T, Morita K, et al (2011). Down-regulation of keratin 4 and keratin 13 expression in oral squamous cell carcinoma and epithelial dysplasia:a clue for the histopathogenesis. Histopathol, 58, 531-42. https://doi.org/10.1111/j.1365-2559.2011.03759.x
  12. Takada M, Masuda N, Matsuura E, et al (1995). Measurement of cytokeratin 19 fragments as a marker of lung cancer by CYFRA 21-1 enzyme immunoassay. Br J Cancer, 71, 160-5. https://doi.org/10.1038/bjc.1995.33
  13. Waseem A, Dogan B, Tidman N, et al (1999). Keratin 15 expression in stratified epithelia: downregulation in activated keratinocytes. J Invest Dermatol, 112, 362-9. https://doi.org/10.1046/j.1523-1747.1999.00535.x
  14. Zhan Q, Signoretti S, Whitaker Menezes D, et al (2007). Cytokeratin15-positive basal epithelial cells targeted in graft-versus-host disease express a constitutive antiapoptotic phenotype. J Invest Dermatol, 127, 106-15. https://doi.org/10.1038/sj.jid.5700583